1984
Neurotransmitter Ontogeny as a Perspective for Studies of Child Development and Pathology
Young J, Cohen D, Anderson G, Shaywitz B. Neurotransmitter Ontogeny as a Perspective for Studies of Child Development and Pathology. 1984, 51-84. DOI: 10.1007/978-94-011-6701-7_4.Peer-Reviewed Original Research
1983
10 Clinical Studies of MHPG in Childhood and Adolescence**The research was supported in part by MHCRC grant MH30929, CCRC grant RR00125, NICHD grant HD-03008, the W. T. Grant Foundation, the MacArthur Foundation, Mr. Leonard Berger, and The Solomon R. & Rebecca D. Baker Foundation, Inc.
YOUNG J, COHEN D, SHAYWITZ B, ANDERSON G, MAAS J. 10 Clinical Studies of MHPG in Childhood and Adolescence**The research was supported in part by MHCRC grant MH30929, CCRC grant RR00125, NICHD grant HD-03008, the W. T. Grant Foundation, the MacArthur Foundation, Mr. Leonard Berger, and The Solomon R. & Rebecca D. Baker Foundation, Inc. 1983, 193-218. DOI: 10.1016/b978-0-12-462920-2.50016-7.Peer-Reviewed Original Research
1982
Clinical neurochemistry of autism and associated disorders
Young J, Kavanagh M, Anderson G, Shaywitz B, Cohen D. Clinical neurochemistry of autism and associated disorders. Journal Of Autism And Developmental Disorders 1982, 12: 147-165. PMID: 6184361, DOI: 10.1007/bf01531305.Peer-Reviewed Original ResearchConceptsNorepinephrine metabolismNeurochemical methodsClinical neurochemistryClinical studiesNeurochemical studiesBehavioral deficitsBiochemical dysfunctionBrain functionAutistic syndromeInfantile autismLow levelsNew studiesAutismDysfunctionSerotoninSyndromeAutistic individualsSymptomsNeurochemistryBrainMajor obstacle